Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who ...

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and ...

Researchers have identified the SHP protein as a key regulator that suppresses cartilage-degrading enzymes and slows osteoarthritis progression.

Engineering biology has the potential to transform how we approach healthcare, food production, manufacturing and our ...

Persistence is also central to the questions he studies. His work examines how the brain generates responses that unfold over ...